FDA Pharmacogenomics Advisory Committee Will Oversee Data Submissions
Executive Summary
FDA is forming a pharmacogenomics advisory committee to handle voluntary genomic data submissions, Office of Clinical Pharmacology & Biopharmaceutics Director Lawrence Lesko, PhD, said
You may also be interested in...
FDA Ad Warning Letters On Track For Significant Increase In 2005
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005
FDA Ad Warning Letters On Track For Significant Increase In 2005
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005
Biomarker Working Group To Explore Development Of Guidance
An FDA working group will be formed by year-end to consider the development of a guidance on biomarkers